The use of biological products derived from U-MSC obtained from Wharton's gelatin (mesenchymal cells and exosomes derived from the umbilical cord) improve organ function, exert immunomodulatory effects, repair, regenerate and anti-inflammatory effect of affected tissues in the entire system, while exhibiting an exemplary safety profile.

The StemSpine® protocol targets injured vertebral structures by directly applying biologics derived from umbilical cord mesenchymal stem cells (U-MSCs). This approach aims to deliver immunomodulatory, reparative, regenerative, and anti-inflammatory effects to the affected areas, such as intervertebral discs or vertebrae, enhancing healing and improving spine conditions.

Joint injections entail the targeted application of biologics derived from U-MSC stem cells to injured joints. The biological product is deposited directly at the site of the injury (such as the tendon, joint, or joint capsule), enabling immunomodulatory, reparative, regenerative, and anti-inflammatory effects.

Intradermal application of U-MSC-derived exosomes to the face stimulates the production of elastin and collagen. This leads to a natural, lifted, and refreshed appearance of the patient's facial dermis.

The Stem Grow treatment targets both halting hair loss and enhancing the quality and thickness of the hair. Utilizing biological products derived from U-MSC, it aims to regenerate hair, counteract pathological mechanisms contributing to hair loss, and stimulate damaged hair follicles. This treatment entails the subdermal application of exosomes to the scalp.

This treatment enhances blood flow, circulation, and nerve regeneration in the sexual organs, providing an opportunity to revitalize your sexual health.

Administering U-MSC-derived exosomes intranasally through nebulization has the potential to enhance neuroprotection, stimulate neurogenesis, and improve respiratory tract function.